Peroral Endoscopic Myotomy for the Treatment of Achalasia
Study Details
Study Description
Brief Summary
There will be a retrospective chart review for patients who underwent endoscopic procedures and POEM from 06/2016 - 01/2019 & a prospective chart review will be performed for patients who will undergo endoscopic procedures and POEM from 02/2019 - 06/2021
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Subjects will undergo no additional tests and procedures as part of this study. All data will be collected from patient's electronic health records (EHR) of the hospital In addition; a prospective chart review will be performed for patients who will undergo endoscopic procedures and POEM from 02/2019 - 06/2021. All the subjects enrolled in prospective chart review will be first consented for their study participation. Subjects will undergo a clinically indicated endoscopic procedure and POEM and subsequent follow-up clinical visits as part of their standard medical care. All procedures, barring research activities such as consenting and data collection from Electronic Health Records, will be either clinically indicated and/or standard of care.
-
Each patient in the study will be assigned a Case ID number to de-identify their personal health information during data collection
-
The Case ID number connecting the patient to the personal health information will be in an encrypted electronic file on a computer that can only be accessed by study members at MDMC.
-
A procedure report and outpatient clinical records for each subject's POEM procedure will be used to record each patient's data for the registry
-
That data will only be shared by members of the study (PIs, research coordinator) who require it for conducting of data collection/interpretation
"Disclaimer: Any cost associated with the procedures stated herein will be billed directly to you or to your insurance (as applicable)."
Study Design
Outcome Measures
Primary Outcome Measures
- Decrease or no symptoms of chest pain [upto 180 days]
To continue and review our treatment outcomes, patient safety in cases with achalasia, we follow up after the procedure up to 180 days. Follow-up period varies from patient to patient.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Any discharged patient who has undergone clinically indicated and/or standard of care POEM for the treatment of Achalasia from 6/2016 to 6/2021.
-
Above or equal to 18 years of age
Exclusion Criteria:
-
Any patient who has not undergone POEM for the treatment of Achalasia.
-
Below 18 years of age
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Methodist Dallas Medical Center | Dallas | Texas | United States | 75203 |
Sponsors and Collaborators
- Methodist Health System
Investigators
- Principal Investigator: Prashant Kedia, M.D., Methodist Dallas Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 031.GID.2018.D